A Better Newspaper

## Overview Researchers have reportedly found a new way to potentially eliminate HIV soon after infection using a one-time combination of three therapies, according to a study covered by ScienceDaily (ScienceDaily, August 12). In newborn nonhuman primates treated within three days of exposure, the regimen completely cleared the virus, even though none of the three components could achieve this individually (ScienceDaily, August 12). ## The Regimen The triple-treatment approach combines: 1. Standard antiretroviral drugs 2. Broadly neutralizing antibodies 3. The experimental antibody leronlimab According to the report, this combination completely cleared the virus in newborn nonhuman primates treated within three days of exposure—a striking result given that none of the individual treatments alone could achieve full clearance (ScienceDaily, August 12). ## Why This Matters This research represents a potentially significant advance in pediatric HIV treatment, particularly for reducing mother-to-child transmission outcomes in regions where HIV remains a major public health burden. If validated in further studies and eventually in human trials, an early triple-therapy intervention could transform post-exposure prophylaxis protocols for newborns. ## Context This finding connects to broader ongoing research into HIV functional cures and prevention, including work on drugs like lenacapavir for HIV prevention access. The use of leronlimab, an experimental antibody, alongside established antiretrovirals and broadly neutralizing antibodies suggests a multi-pronged strategy gaining traction in HIV cure research. ## Developments to Watch - Progression toward human clinical trials - Regulatory pathway for leronlimab given its experimental status - Replication of results in additional primate cohorts - Potential adoption by global health bodies for perinatal HIV prevention protocols